Details for Patent: 3,793,457

Summary for Patent: 3,793,457

Title:	Therapeutically active phenylalkane derivatives
Abstract:	2-(2-FLUORO-4-BIPHENYLYL)PROPIONIC ACID, 2-(2,2''-FLUORO4-BIPHENYLYL) PROPIONIC ACID AND 2-(2,2''-DIFLUORO-4-BIHENYLYL) PROPIONIC ACID POSSESSING GREAT ANTI-INFLAMMATORY, ANALGESIC, AND ANTIPYRETIC ACTIVITIES.
Inventor(s):	S Adams, B Armitage, J Nicholson, A Blancafort
Assignee:	Boots Co PLC
Application Number:	US00308558A
Patent Claim Types: see list of patent claims

What Does US Patent 3,793,457 Claim and Where Does It Fit in the US Patent Landscape?

Insufficient information was provided to complete a scope-and-claims and landscape analysis of United States Drug Patent 3,793,457. The prompt includes only: “The claims are:” without the actual claim text (or claim enumeration). Without the claim language, a complete and accurate scope assessment and a credible freedom-to-operate style landscape mapping cannot be produced.

What Is the Claim Scope of US 3,793,457?

No claim text or claim numbers were supplied in the request, so the scope cannot be reconstructed.

What Is the Patent’s Effective Claim Coverage (Compositions, Processes, and Methods)?

No claim language was supplied, so coverage across composition, process, and method-of-treatment elements cannot be determined.

What Related Patents Form the Surrounding US Landscape?

No landscape inputs were provided and no cited references, assignee, drug substance, formulation, synthesis steps, or therapeutic use were provided. As a result, adjacent families and continuation/derivative filings cannot be identified and mapped to the relevant US claim positions.

Key Takeaways

• No claim text for US 3,793,457 was provided, so claim scope cannot be analyzed.
• No bibliographic details, asserted indications, active ingredient, or claim-dependent structure was provided, so landscape mapping cannot be completed.

FAQs

1. What information is needed to analyze claim scope for US 3,793,457?
   The full claim text (including claim dependencies), plus bibliographic fields (at minimum, title/assignee and the drug substance), are required to evaluate scope.

2. Can I still do a landscape analysis without the claims?
   Not to a standard suitable for investment or R&D decision-making, because adjacency and relevance depend on the exact claimed elements.

3. What parts of the claims matter most for drug patents?
   Typically the independent claim structure and any claim dependencies that constrain the active ingredient, formulation parameters, dosing, and method-of-use features.

4. How is “scope” different from “landscape”?
   Scope explains what the patent legally covers. Landscape identifies how other patents compete, overlap, or design around those specific claim elements.

5. Will claim interpretation change over time?
   Yes, especially if courts construe terms or if prosecution history and continuations affect the interpretation, but that requires the actual claim language and prosecution record.

Drugs Protected by US Patent 3,793,457

Applicant	Tradename	Generic Name	Dosage	NDA	Approval Date	TE	Type	RLD	RS	Patent No.	Patent Expiration	Product	Substance	Delist Req.	Patented / Exclusive Use	Submissiondate

International Family Members for US Patent 3,793,457

Country	Patent Number	Estimated Expiration	Supplementary Protection Certificate	SPC Country	SPC Expiration
Belgium	658723
Switzerland	454822
Switzerland	501577
Czechoslovakia	163156